학술논문
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
Document Type
Article
Author
Eikelboom, J.W.; Bosch, J.; Connolly, S.J.; Tyrwitt, J.; Bangdiwala, S.I.; Leong, D.P.; Lonn, E.M.; Anand, S.S.; Lamy, A.; Sharma, M.; Yusuf, S.; Fox, K.A.A.; Muehlhofer, E.; Neumann, C.; Tasto, C.; Diaz, R.; Alings, M.; Dagenais, G.R.; Avezum, A.; Piegas, L.S.; Widimsky, P.; Parkhomenko, A.N.; Bhatt, D.L.; Branch, K.R.H.; Probstfield, J.L.; Lopez-Jaramillo, P.; Rydén, L.; Pogosova, N.; Keltai, K.; Keltai, M.; Ertl, G.; Stoerk, S.; Dans, A.L.; Lanas, F.; Liang, Y.; Zhu, J.; Torp-Pedersen, C.; Maggioni, A.P.; Commerford, P.J.; Guzik, T.J.; Vanassche, T.; Verhamme, P.; O'donnell, M.; Tonkin, A.M.; Varigos, J.D.; Vinereanu, D.; Felix, C.; Kim, J.-H.; Ibrahim, K.S.; Lewis, B.S.; Metsarinne, K.P.; Aboyans, V.; Steg, P.G.; Hori, M.; Kakkar, A.
Source
In: European Heart Journal - Cardiovascular Pharmacotherapy . (European Heart Journal - Cardiovascular Pharmacotherapy, 1 December 2022, 8(8):786-795)
Subject
Language
English
ISSN
20556845
20556837
20556837